Trident Texofab reports no deviation in the utilisation of funds raised from the preferential warrants as of 31 December 2025, with auditor confirmation and Audit Committee review.
AI Assistant
Trident Texofab Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.